Current Progress and Future Outlook for Synthetic Gene Circuits in Cardiovascular Therapy
Biomolecules · 21.05.2026 · 16 (5) · 754
DOI: 10.3390/biom16050754 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Biomolecules, online erschienen am 21.05.2026. Verfasst von Mohammadali Khalilitousi und 3 weiteren Autor:innen. Beteiligte Einrichtung: School of Biomedical Engineering, The University of British Columbia, Vancouver, BC V6T 1Z4, Canada. Hauptthemen laut MEDLINE: Gene Regulatory Networks, Cardiovascular Diseases, Synthetic Biology, Genetic Therapy. Die Arbeit nennt 85 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Despite decades of therapeutic advances, cardiovascular diseases remain the leading cause of global mortality, underscoring the need for strategies that move beyond untargeted systemic pharmacotherapy. Synthetic biology introduces a programmable therapeutic paradigm in which engineered gene circuits can sense, compute, and respond to pathological signals with spatiotemporal precision. This review examines the current progress of synthetic gene circuits for cardiovascular therapy, organized across three domains of clinical relevance. The first domain comprises circuits engineered for direct cardiac applications, from inducible switches to classifier systems. This discussion is further expanded by exploring circuits that indirectly target cardiovascular disease; these circuits address upstream risk factors such as cholesterol dysregulation and chronic inflammation. Looking ahead, the focus shifts to orthogonal architectures pioneered in other therapeutic contexts that hold promise for future cardiac applications. This review further discusses the emerging role of computational tools, including gene regulatory network inference and foundation models, in accelerating target discovery. Finally, a modified Design-Build-Test-Learn framework is proposed to overcome translational bottlenecks, thus paving the way for next-generation cardiac therapeutics.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- School of Biomedical Engineering, The University of British Columbia, Vancouver, BC V6T 1Z4, Canada.
- Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.
ORCID-Profile: Mohammadali Khalilitousi, Arshaan Dhingra
Zitieren
APA
Khalilitousi, M., Dhingra, A., Rohani, L., & Weiss, R. (2026). Current Progress and Future Outlook for Synthetic Gene Circuits in Cardiovascular Therapy. Biomolecules, 16(5), 754. https://doi.org/10.3390/biom16050754
Vancouver
Khalilitousi M, Dhingra A, Rohani L, Weiss R. Current Progress and Future Outlook for Synthetic Gene Circuits in Cardiovascular Therapy. Biomolecules. 2026;16(5):754. doi:10.3390/biom16050754
BibTeX
@article{Khalilitousi2026,
author = {Khalilitousi, Mohammadali and Dhingra, Arshaan and Rohani, Leili and Weiss, Ron},
title = {Current Progress and Future Outlook for Synthetic Gene Circuits in Cardiovascular Therapy},
journal = {Biomolecules},
year = {2026},
volume = {16},
number = {5},
pages = {754},
doi = {10.3390/biom16050754}
}
EUVIMED